 Jeffrey Brent
Concepts (290)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Poisoning | 21 | 2025 | 119 | 3.500 |
Why?
| | Drug Overdose | 27 | 2026 | 375 | 3.240 |
Why?
| | Toxicology | 14 | 2025 | 49 | 2.610 |
Why?
| | Analgesics, Opioid | 26 | 2026 | 1154 | 1.960 |
Why?
| | Registries | 31 | 2025 | 2410 | 1.690 |
Why?
| | Methanol | 4 | 2021 | 44 | 1.440 |
Why?
| | Ethylene Glycol | 5 | 2022 | 15 | 1.280 |
Why?
| | Antidotes | 8 | 2023 | 145 | 1.260 |
Why?
| | Emergency Service, Hospital | 23 | 2026 | 2383 | 1.240 |
Why?
| | Acidosis | 3 | 2022 | 105 | 1.020 |
Why?
| | Tramadol | 6 | 2024 | 17 | 0.970 |
Why?
| | Cannabinoids | 3 | 2022 | 184 | 0.860 |
Why?
| | Cocaine | 3 | 2026 | 162 | 0.850 |
Why?
| | Decontamination | 2 | 2014 | 28 | 0.790 |
Why?
| | Burns, Chemical | 2 | 2014 | 33 | 0.790 |
Why?
| | Bias | 1 | 2024 | 197 | 0.780 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 7 | 2018 | 261 | 0.770 |
Why?
| | Snake Bites | 5 | 2022 | 24 | 0.760 |
Why?
| | Butterflies | 1 | 2023 | 21 | 0.750 |
Why?
| | Opiate Alkaloids | 1 | 2022 | 6 | 0.740 |
Why?
| | Mesothelioma | 1 | 2023 | 52 | 0.740 |
Why?
| | Moths | 1 | 2023 | 45 | 0.740 |
Why?
| | Substance-Related Disorders | 7 | 2025 | 1102 | 0.730 |
Why?
| | Poisons | 1 | 2021 | 20 | 0.680 |
Why?
| | Fentanyl | 6 | 2024 | 128 | 0.680 |
Why?
| | Pyrazoles | 4 | 2021 | 517 | 0.640 |
Why?
| | Cobalt | 2 | 2017 | 50 | 0.620 |
Why?
| | Hip Prosthesis | 2 | 2017 | 42 | 0.610 |
Why?
| | Benzodiazepines | 4 | 2025 | 168 | 0.610 |
Why?
| | Abortion, Induced | 1 | 2022 | 111 | 0.610 |
Why?
| | Referral and Consultation | 9 | 2025 | 868 | 0.590 |
Why?
| | Skin | 2 | 2014 | 754 | 0.560 |
Why?
| | Metformin | 1 | 2022 | 329 | 0.540 |
Why?
| | Metal-on-Metal Joint Prostheses | 1 | 2017 | 2 | 0.530 |
Why?
| | Hypoglycemia | 2 | 2022 | 480 | 0.530 |
Why?
| | Chromium | 1 | 2017 | 18 | 0.520 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2017 | 183 | 0.510 |
Why?
| | Humans | 83 | 2026 | 145763 | 0.510 |
Why?
| | Prospective Studies | 23 | 2026 | 8075 | 0.500 |
Why?
| | United States | 31 | 2026 | 16123 | 0.500 |
Why?
| | Adult | 45 | 2026 | 40872 | 0.470 |
Why?
| | Suicide, Attempted | 5 | 2024 | 426 | 0.460 |
Why?
| | Chelating Agents | 3 | 2021 | 76 | 0.460 |
Why?
| | Drug Contamination | 2 | 2026 | 54 | 0.450 |
Why?
| | Chelation Therapy | 2 | 2013 | 10 | 0.430 |
Why?
| | Opioid-Related Disorders | 4 | 2026 | 605 | 0.420 |
Why?
| | Middle Aged | 37 | 2026 | 36302 | 0.410 |
Why?
| | Mercury Poisoning, Nervous System | 1 | 2013 | 2 | 0.410 |
Why?
| | Substance Abuse Detection | 4 | 2025 | 110 | 0.410 |
Why?
| | Young Adult | 26 | 2026 | 14251 | 0.390 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2013 | 65 | 0.390 |
Why?
| | Central Nervous System Stimulants | 2 | 2025 | 185 | 0.390 |
Why?
| | Bupropion | 2 | 2024 | 48 | 0.380 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 1101 | 0.380 |
Why?
| | Inappropriate Prescribing | 1 | 2013 | 66 | 0.380 |
Why?
| | Male | 49 | 2026 | 73003 | 0.370 |
Why?
| | Decision Support Techniques | 1 | 2017 | 480 | 0.360 |
Why?
| | Antivenins | 4 | 2022 | 29 | 0.350 |
Why?
| | Paraquat | 1 | 2011 | 13 | 0.350 |
Why?
| | Narcotic Antagonists | 6 | 2025 | 203 | 0.350 |
Why?
| | Naloxone | 8 | 2025 | 132 | 0.350 |
Why?
| | Herbicides | 1 | 2011 | 27 | 0.340 |
Why?
| | Parkinsonian Disorders | 1 | 2011 | 43 | 0.340 |
Why?
| | Female | 48 | 2026 | 79035 | 0.330 |
Why?
| | Hallucinogens | 2 | 2023 | 111 | 0.310 |
Why?
| | Analgesics, Non-Narcotic | 3 | 2023 | 128 | 0.310 |
Why?
| | Methadone | 3 | 2020 | 123 | 0.300 |
Why?
| | Pharmacovigilance | 3 | 2024 | 24 | 0.300 |
Why?
| | Child | 24 | 2025 | 22739 | 0.280 |
Why?
| | Aged | 19 | 2023 | 26215 | 0.280 |
Why?
| | Levamisole | 2 | 2026 | 22 | 0.280 |
Why?
| | Xylazine | 2 | 2026 | 16 | 0.280 |
Why?
| | Adolescent | 23 | 2025 | 22573 | 0.280 |
Why?
| | Time Factors | 9 | 2025 | 7133 | 0.250 |
Why?
| | Child, Preschool | 17 | 2025 | 11868 | 0.250 |
Why?
| | Adenosine Monophosphate | 2 | 2024 | 85 | 0.240 |
Why?
| | Alanine | 2 | 2024 | 169 | 0.230 |
Why?
| | Adrenergic alpha-2 Receptor Agonists | 1 | 2026 | 26 | 0.230 |
Why?
| | Edema | 2 | 2023 | 125 | 0.220 |
Why?
| | Cannabis | 2 | 2023 | 510 | 0.220 |
Why?
| | Treatment Outcome | 10 | 2020 | 11793 | 0.220 |
Why?
| | Seizures | 3 | 2021 | 485 | 0.210 |
Why?
| | Patient Outcome Assessment | 1 | 2025 | 130 | 0.210 |
Why?
| | Infant | 13 | 2025 | 10090 | 0.210 |
Why?
| | Intubation, Intratracheal | 2 | 2025 | 327 | 0.210 |
Why?
| | Plant Poisoning | 1 | 2023 | 8 | 0.200 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2023 | 29 | 0.200 |
Why?
| | Talc | 1 | 2023 | 9 | 0.190 |
Why?
| | Cohort Studies | 10 | 2024 | 6032 | 0.190 |
Why?
| | Anticonvulsants | 3 | 2022 | 246 | 0.190 |
Why?
| | Metals, Heavy | 2 | 2021 | 31 | 0.190 |
Why?
| | Predictive Value of Tests | 4 | 2017 | 2123 | 0.190 |
Why?
| | Self-Injurious Behavior | 1 | 2024 | 141 | 0.190 |
Why?
| | Amphetamines | 1 | 2022 | 6 | 0.190 |
Why?
| | Psychotropic Drugs | 4 | 2023 | 78 | 0.190 |
Why?
| | Prescription Drug Misuse | 2 | 2021 | 53 | 0.180 |
Why?
| | Multicenter Studies as Topic | 1 | 2024 | 413 | 0.180 |
Why?
| | Diphenhydramine | 1 | 2022 | 36 | 0.180 |
Why?
| | Ivermectin | 1 | 2022 | 15 | 0.180 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2025 | 288 | 0.180 |
Why?
| | Foodborne Diseases | 1 | 2023 | 60 | 0.180 |
Why?
| | Snakes | 2 | 2022 | 19 | 0.180 |
Why?
| | Caffeine | 1 | 2022 | 74 | 0.180 |
Why?
| | Narcotics | 1 | 2022 | 58 | 0.180 |
Why?
| | Larva | 1 | 2023 | 240 | 0.180 |
Why?
| | Sulfonylurea Compounds | 1 | 2022 | 51 | 0.180 |
Why?
| | Vertigo | 1 | 2022 | 55 | 0.170 |
Why?
| | Nausea | 1 | 2022 | 112 | 0.170 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 65 | 0.170 |
Why?
| | Acetaminophen | 2 | 2022 | 267 | 0.170 |
Why?
| | Tremor | 1 | 2022 | 98 | 0.170 |
Why?
| | Vomiting | 1 | 2022 | 131 | 0.170 |
Why?
| | Dizziness | 1 | 2022 | 101 | 0.170 |
Why?
| | Diarrhea | 1 | 2022 | 193 | 0.160 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 498 | 0.160 |
Why?
| | Coral Snakes | 1 | 2020 | 3 | 0.160 |
Why?
| | Elapid Venoms | 1 | 2020 | 13 | 0.160 |
Why?
| | Abdominal Pain | 1 | 2022 | 149 | 0.160 |
Why?
| | Research Personnel | 4 | 2022 | 185 | 0.160 |
Why?
| | Analgesics | 1 | 2022 | 231 | 0.160 |
Why?
| | Eating | 1 | 2023 | 387 | 0.160 |
Why?
| | Patient-Centered Care | 1 | 2025 | 547 | 0.160 |
Why?
| | Crotalus | 1 | 2020 | 24 | 0.160 |
Why?
| | Crotalid Venoms | 1 | 2020 | 30 | 0.150 |
Why?
| | Creatinine | 1 | 2022 | 515 | 0.150 |
Why?
| | Risk Factors | 7 | 2024 | 10917 | 0.150 |
Why?
| | Nicotine | 1 | 2022 | 331 | 0.150 |
Why?
| | Rhabdomyolysis | 1 | 2019 | 24 | 0.150 |
Why?
| | Blood Chemical Analysis | 2 | 2010 | 109 | 0.150 |
Why?
| | Heavy Metal Poisoning | 2 | 2021 | 3 | 0.150 |
Why?
| | Antidiarrheals | 1 | 2018 | 12 | 0.140 |
Why?
| | Loperamide | 1 | 2018 | 12 | 0.140 |
Why?
| | Antidepressive Agents | 3 | 2016 | 242 | 0.140 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2019 | 73 | 0.140 |
Why?
| | Prevalence | 3 | 2024 | 2874 | 0.140 |
Why?
| | Annual Reports as Topic | 1 | 2018 | 2 | 0.140 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 440 | 0.140 |
Why?
| | Retrospective Studies | 7 | 2024 | 17325 | 0.140 |
Why?
| | Biomedical Research | 1 | 2025 | 719 | 0.140 |
Why?
| | Crime | 1 | 2019 | 57 | 0.140 |
Why?
| | Viperidae | 1 | 2018 | 6 | 0.140 |
Why?
| | Animals | 10 | 2023 | 38097 | 0.140 |
Why?
| | Healthcare Disparities | 1 | 2025 | 736 | 0.140 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2018 | 56 | 0.130 |
Why?
| | Biomarkers | 4 | 2022 | 4302 | 0.130 |
Why?
| | Israel | 2 | 2017 | 46 | 0.130 |
Why?
| | Hospital Mortality | 4 | 2025 | 1038 | 0.130 |
Why?
| | Drug Misuse | 1 | 2017 | 2 | 0.130 |
Why?
| | London | 1 | 2017 | 46 | 0.130 |
Why?
| | Prognosis | 4 | 2022 | 4329 | 0.130 |
Why?
| | Renal Insufficiency | 1 | 2019 | 172 | 0.130 |
Why?
| | Aged, 80 and over | 7 | 2019 | 8346 | 0.120 |
Why?
| | Pediatrics | 3 | 2018 | 1125 | 0.120 |
Why?
| | Bicarbonates | 2 | 2022 | 45 | 0.120 |
Why?
| | Neurologic Examination | 1 | 2017 | 132 | 0.120 |
Why?
| | Prosthesis Failure | 1 | 2017 | 125 | 0.120 |
Why?
| | Crime Victims | 1 | 2019 | 131 | 0.120 |
Why?
| | Designer Drugs | 1 | 2016 | 7 | 0.120 |
Why?
| | Brain Death | 1 | 2017 | 60 | 0.120 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2018 | 185 | 0.120 |
Why?
| | Disease Outbreaks | 1 | 2019 | 419 | 0.120 |
Why?
| | North America | 3 | 2022 | 303 | 0.110 |
Why?
| | Odds Ratio | 1 | 2017 | 1083 | 0.110 |
Why?
| | Chronic Pain | 1 | 2019 | 292 | 0.100 |
Why?
| | Pregnancy | 3 | 2023 | 7215 | 0.100 |
Why?
| | Hypnotics and Sedatives | 1 | 2016 | 222 | 0.100 |
Why?
| | Body Burden | 1 | 2013 | 7 | 0.100 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 874 | 0.100 |
Why?
| | Hydrofluoric Acid | 1 | 2013 | 7 | 0.100 |
Why?
| | Tertiary Care Centers | 1 | 2015 | 195 | 0.100 |
Why?
| | Length of Stay | 2 | 2025 | 1350 | 0.100 |
Why?
| | Poison Control Centers | 2 | 2015 | 85 | 0.100 |
Why?
| | Hospitalization | 4 | 2022 | 2460 | 0.100 |
Why?
| | Urinalysis | 1 | 2013 | 83 | 0.100 |
Why?
| | Unnecessary Procedures | 1 | 2013 | 54 | 0.100 |
Why?
| | Chromatography, Liquid | 2 | 2025 | 450 | 0.100 |
Why?
| | Alanine Transaminase | 2 | 2024 | 151 | 0.100 |
Why?
| | International Cooperation | 1 | 2013 | 197 | 0.090 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3416 | 0.090 |
Why?
| | Australia | 1 | 2013 | 291 | 0.090 |
Why?
| | Data Mining | 1 | 2013 | 113 | 0.090 |
Why?
| | Organic Chemicals | 1 | 2013 | 112 | 0.090 |
Why?
| | Ethanol | 2 | 2023 | 631 | 0.090 |
Why?
| | Canada | 1 | 2013 | 432 | 0.090 |
Why?
| | Hypoglycemic Agents | 1 | 2022 | 1399 | 0.090 |
Why?
| | Coma | 2 | 2023 | 38 | 0.090 |
Why?
| | Renal Dialysis | 2 | 2019 | 466 | 0.090 |
Why?
| | Hospitals, Pediatric | 1 | 2015 | 558 | 0.080 |
Why?
| | Cooperative Behavior | 1 | 2013 | 463 | 0.080 |
Why?
| | Glycols | 1 | 2010 | 5 | 0.080 |
Why?
| | Ethylenes | 1 | 2010 | 16 | 0.080 |
Why?
| | Ethylene Glycols | 1 | 2010 | 17 | 0.080 |
Why?
| | Consultants | 1 | 2010 | 12 | 0.080 |
Why?
| | Compensation and Redress | 1 | 2010 | 8 | 0.080 |
Why?
| | Water | 1 | 2013 | 447 | 0.080 |
Why?
| | Half-Life | 1 | 2010 | 155 | 0.080 |
Why?
| | Injections, Intravenous | 1 | 2010 | 197 | 0.080 |
Why?
| | Blood Glucose | 1 | 2020 | 2344 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2013 | 740 | 0.080 |
Why?
| | Pregnancy Complications | 1 | 2015 | 603 | 0.080 |
Why?
| | Disease Progression | 2 | 2023 | 2865 | 0.070 |
Why?
| | Societies, Medical | 1 | 2013 | 900 | 0.070 |
Why?
| | Osmolar Concentration | 1 | 2009 | 168 | 0.070 |
Why?
| | HIV Infections | 1 | 2024 | 3195 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2933 | 0.070 |
Why?
| | Buprenorphine | 2 | 2025 | 192 | 0.070 |
Why?
| | Clinical Trials as Topic | 1 | 2013 | 1062 | 0.070 |
Why?
| | Infant, Newborn | 3 | 2020 | 6464 | 0.070 |
Why?
| | Survivors | 1 | 2011 | 523 | 0.070 |
Why?
| | Databases, Factual | 3 | 2017 | 1491 | 0.060 |
Why?
| | Missouri | 1 | 2024 | 66 | 0.050 |
Why?
| | Pennsylvania | 1 | 2024 | 138 | 0.050 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2024 | 46 | 0.050 |
Why?
| | Outpatients | 2 | 2021 | 447 | 0.050 |
Why?
| | Amines | 1 | 2023 | 40 | 0.050 |
Why?
| | Health Personnel | 1 | 2010 | 757 | 0.050 |
Why?
| | Alcoholism | 1 | 2010 | 826 | 0.050 |
Why?
| | Piperidines | 1 | 2024 | 222 | 0.050 |
Why?
| | Inpatients | 2 | 2021 | 553 | 0.050 |
Why?
| | Phenacetin | 1 | 2022 | 1 | 0.050 |
Why?
| | Alprazolam | 1 | 2022 | 6 | 0.050 |
Why?
| | Lactic Acid | 1 | 2024 | 295 | 0.050 |
Why?
| | Codeine | 1 | 2022 | 7 | 0.050 |
Why?
| | Glycolates | 1 | 2022 | 6 | 0.050 |
Why?
| | Bradycardia | 1 | 2023 | 61 | 0.050 |
Why?
| | Risk Assessment | 3 | 2019 | 3752 | 0.050 |
Why?
| | Heroin | 1 | 2022 | 29 | 0.040 |
Why?
| | Sucrose | 1 | 2022 | 114 | 0.040 |
Why?
| | Chloroquine | 1 | 2022 | 54 | 0.040 |
Why?
| | United States Food and Drug Administration | 1 | 2023 | 208 | 0.040 |
Why?
| | Age Factors | 2 | 2020 | 3346 | 0.040 |
Why?
| | Attitude of Health Personnel | 1 | 2010 | 1197 | 0.040 |
Why?
| | Quercetin | 1 | 2021 | 19 | 0.040 |
Why?
| | Patient Participation | 1 | 2025 | 446 | 0.040 |
Why?
| | Diazepam | 1 | 2021 | 33 | 0.040 |
Why?
| | Practice Guidelines as Topic | 1 | 2009 | 1582 | 0.040 |
Why?
| | Benzimidazoles | 1 | 2022 | 189 | 0.040 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2020 | 44 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5922 | 0.040 |
Why?
| | Paresthesia | 1 | 2020 | 14 | 0.040 |
Why?
| | Erythema | 1 | 2020 | 28 | 0.040 |
Why?
| | Antiemetics | 1 | 2020 | 51 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2021 | 450 | 0.040 |
Why?
| | Iron | 1 | 2022 | 359 | 0.040 |
Why?
| | Emergency Treatment | 1 | 2021 | 123 | 0.040 |
Why?
| | Texas | 1 | 2020 | 273 | 0.040 |
Why?
| | Alcoholic Beverages | 1 | 2019 | 31 | 0.040 |
Why?
| | Research Design | 1 | 2025 | 1139 | 0.040 |
Why?
| | Weapons of Mass Destruction | 1 | 2018 | 1 | 0.040 |
Why?
| | Atrioventricular Block | 1 | 2018 | 44 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2024 | 769 | 0.030 |
Why?
| | Long QT Syndrome | 1 | 2018 | 68 | 0.030 |
Why?
| | Retreatment | 1 | 2017 | 80 | 0.030 |
Why?
| | Demography | 1 | 2018 | 282 | 0.030 |
Why?
| | Critical Illness | 1 | 2023 | 900 | 0.030 |
Why?
| | Toxiferine | 1 | 2016 | 1 | 0.030 |
Why?
| | Respiratory Insufficiency | 1 | 2020 | 326 | 0.030 |
Why?
| | Triage | 1 | 2019 | 250 | 0.030 |
Why?
| | Pharmaceutical Preparations | 1 | 2018 | 171 | 0.030 |
Why?
| | Opiate Substitution Treatment | 1 | 2019 | 189 | 0.030 |
Why?
| | Sentinel Surveillance | 1 | 2016 | 46 | 0.030 |
Why?
| | Societies, Scientific | 1 | 2016 | 50 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2020 | 379 | 0.030 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 356 | 0.030 |
Why?
| | Patient Admission | 1 | 2017 | 220 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 904 | 0.030 |
Why?
| | Electrocardiography | 1 | 2018 | 668 | 0.030 |
Why?
| | Nonprescription Drugs | 1 | 2015 | 69 | 0.030 |
Why?
| | Pain | 1 | 2020 | 791 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1711 | 0.030 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2015 | 98 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4556 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 364 | 0.020 |
Why?
| | Program Evaluation | 1 | 2017 | 944 | 0.020 |
Why?
| | Rats | 1 | 2021 | 5585 | 0.020 |
Why?
| | Device Removal | 1 | 2013 | 142 | 0.020 |
Why?
| | Acute Disease | 1 | 2015 | 1036 | 0.020 |
Why?
| | Oxycodone | 1 | 2012 | 52 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3634 | 0.020 |
Why?
| | Acetylcysteine | 1 | 2012 | 139 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 2191 | 0.020 |
Why?
| | Prosthesis Design | 1 | 2013 | 356 | 0.020 |
Why?
| | Health Promotion | 1 | 2017 | 775 | 0.020 |
Why?
| | Cardiovascular Agents | 1 | 2012 | 166 | 0.020 |
Why?
| | Antipsychotic Agents | 1 | 2012 | 211 | 0.020 |
Why?
| | Administration, Oral | 1 | 2012 | 867 | 0.020 |
Why?
| | Data Collection | 1 | 2011 | 643 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 2015 | 684 | 0.020 |
Why?
| | Incidence | 1 | 2012 | 2933 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2010 | 6085 | 0.010 |
Why?
|
|
Brent's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|